---
title: "TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system"
date: "2024-11-01T09:25:03.000Z"
publishedDate: "1 novembre 2024"
summary: "One-year outcomes of the TRAVEL II study, evaluating the Lux-Valve Plus (Jenscare Scientific) transcatheter tricuspid valve replacement, were released at TCT 2024 (27–30 October, Washington, DC, USA), showing that LuX-Valve Plus system is safe and effective in achieving short delivery times, low composite event rates, significant tricuspid regurgitation (TR) reduction and improvement in functional and [&#8230;] The post TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/tct-2024-hears-one-year-results-of-travel-ii-study-of-transcatheter-tricuspid-replacement-system/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-11-01-tct-2024-hears-one-year-results-of-travel-ii-study-of-transcatheter-tricuspid-replacement-system"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/11/Granada-TCT.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2024-hears-one-year-results-of-travel-ii-study-of-transcatheter-tricuspid-replacement-system/"
---

![TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/11/Granada-TCT.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2024-hears-one-year-results-of-travel-ii-study-of-transcatheter-tricuspid-replacement-system/*

## L’essentiel

One-year outcomes of the TRAVEL II study, evaluating the Lux-Valve Plus (Jenscare Scientific) transcatheter tricuspid valve replacement, were released at TCT 2024 (27–30 October, Washington, DC, USA), showing that LuX-Valve Plus system is safe and effective in achieving short delivery times, low composite event rates, significant tricuspid regurgitation (TR) reduction and improvement in functional and [&#8230;] The post TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/tct-2024-hears-one-year-results-of-travel-ii-study-of-transcatheter-tricuspid-replacement-system/
